These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7585729)

  • 21. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients.
    Shimamoto Y; Anami Y; Yamaguchi M
    Eur J Haematol; 1991 Oct; 47(4):262-7. PubMed ID: 1954984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic factors in IgG and micromolecular multiple myeloma. Retrospective analysis of 50 consecutive cases].
    Pasqualetti P; Casale R; Colantonio D; Festuccia V; Di Lauro G; Natali G
    Minerva Med; 1987 May; 78(9):603-8. PubMed ID: 3587727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [BUN, Bence Jones protein, and chromosomal aberrations predict survival in multiple myeloma].
    Okada K; Oguchi N; Shinohara K; Tamura N; Ishii K; Noguchi Y; Hayashi S; Yamamoto H; Takeichi M; Fujimoto H; Shirota T; Hayashi T
    Rinsho Ketsueki; 1997 Dec; 38(12):1254-62. PubMed ID: 9455144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of criteria in staging in multiple myeloma.
    Pennec Y; Mottier D; Youinou P; Asselain B; Miossec P; Le Goff P; Le Prise PY; Le Menn G
    Haematologia (Budap); 1982; 15(2):221-6. PubMed ID: 7160667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgD multiple myeloma. A report of three cases.
    Martini R; Santini S; Bottari G
    Minerva Med; 1996 Mar; 87(3):109-12. PubMed ID: 8668286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
    Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
    Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A comparison of staging classifications of plasmacytoma].
    Löffler H; Gassmann W; Haferlach T; Pralle H
    Onkologie; 1986 Aug; 9(4):196, 199-201. PubMed ID: 3531946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of five staging systems in 470 patients with multiple myeloma.
    Mihou D; Katodritou I; Zervas K
    Haematologica; 2006 Aug; 91(8):1149-50. PubMed ID: 16885059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple myeloma index: verification of a new prognostic approach with evaluation of treatment response.
    Bettini R; Tonolini M; Bernasconi M
    Haematologica; 1998 Aug; 83(8):708-13. PubMed ID: 9793254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison among immunologically different subtypes of 595 untreated multiple myeloma patients in northern China.
    Zhang L; Qi JY; Qi PJ; Wang YF; Zou DH; Yao HJ; An G; Yi SH; Li Q; Qiu LG
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):197-204. PubMed ID: 20511165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening of prognostic factors and comparing of staging systems of multiple myeloma].
    Li J; Wu XB; Zhou Y; Wang X; Chen JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):926-9. PubMed ID: 22931656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival in a case of high-risk type IgD myeloma; a possibility of effectiveness of interferon-alpha and erythropoietin.
    Hiyoshi M; Hashimoto S; Ota T; Nakao T; Takubo T; Tagawa S; Tatsumi N
    Haematologia (Budap); 1997; 28(3):177-80. PubMed ID: 9283919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of stratification systems in multiple myeloma. II. Clinical staging systems.
    Scudla V; Indrák K
    Neoplasma; 1985; 32(4):481-93. PubMed ID: 4047259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.